Rescue therapy of tunnel/pocket infections of Hickman-Broviac/Port indwelling central venous catheters with antibiotic continuous infusion - ND

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-002146-10-IT

Enrollment

Registered

2006-08-02

Start date

2006-09-06

Completion date

Unknown

Last updated

2012-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Hemato-oncologic disease or undergoing Hematopoietic stem cell transplantation MedDRA version: 6.1 Level: PT Classification code 10007882

Interventions

Product Name: Vancomycin Pharmaceutical Form: Powder for infusion* INN or Proposed INN: Vancomycin CAS Number: 1404-93-9 Concentration unit: mg milligram(s) Concentration type: equal Concentration num

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Patients with Hickmann-Broviac or Port catheter 2 Presence of catheter related tunnel/pocket infections 3 controindications to CVC removal 4 Infomed consent Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: 1 withdrawal of informed consent 2 Diagnosis of metastatic infection not evident at start of experimental therapy 3 absence of clinical/microbiological response after seven days of treatment 4 Development of adverse events related with experimental therapy

Design outcomes

Primary

Measure	Time frame
Main Objective: Evaluate efficacy of rescue treatment;Secondary Objective: 1. Evaluate tolerability of antibiotic lock 2. Evaluate feasibility of out patient therapy;Primary end point(s): Evaluate efficacy of rescue treatment	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026